Niagen Bioscience (NAGE) Interest Expenses (2010 - 2022)

Niagen Bioscience (NAGE) has 13 years of Interest Expenses data on file, last reported at $5000.0 in Q3 2022.

• Interest Expenses for Q3 2022 came in at $5000.0, down 66.67% year-over-year; the trailing twelve-month figure through Jun 2023 was $5000.0 (down 88.1% YoY), and the FY2021 annual result was $55000.0, down 22.54% from the prior year.
• Interest Expenses fell to $5000.0 in Q3 2022 per NAGE's latest filing, from $10000.0 in the prior quarter.
• Over five years, Interest Expenses peaked at $575000.0 in Q2 2019 and troughed at $5000.0 in Q3 2022.
• A 5-year average of $76266.7 and a median of $16000.0 in 2020 frame the typical range for Interest Expenses.
• The sharpest annual moves came in 2019 and 2020: Interest Expenses soared 3388.89% in 2019, then plunged 95.83% in 2020.
• A 5-year view of Interest Expenses shows it stood at $9000.0 in 2018, then soared by 3388.89% to $314000.0 in 2019, then plunged by 94.9% to $16000.0 in 2020, then plunged by 43.75% to $9000.0 in 2021, then plunged by 44.44% to $5000.0 in 2022.
• Business Quant data shows NAGE's Interest Expenses at $5000.0 in Q3 2022, $10000.0 in Q2 2022, and $8000.0 in Q1 2022.